Author

P. S. Malik

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. Jagjampi· 1 shared A. K. Gupta· 1 shared B. Nayak· 1 shared C. P. Prasad· 1 shared D. Jain· 1 shared D. Pushpam· 1 shared H. Prakash· 1 shared L. Kumar· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. Jagjampi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Synergistic Hypoxia and Apoptosis Conditioning Unleashes Superior Mesenchymal Stem Cells Efficacy in Acute Graft-versus-Host-Disease

M. Mendiratta, M. Mendiratta, S. K. Ganguly, S. Rai, R. Gupta, L. Kumar, S. Bakhshi, V. Dadhwal, D. Pushpam, P. S. Malik, R. Pramanik, M. Aggarwal, A. K. Gupta, R. Dhawan, T. Seth, , R. K. Sahoo

This study shows that hypoxia and apoptosis conditioning of WJ-MSCs enhances their immune regulatory capacity in aGVHD by promoting Treg differentiation and M2 macrophage polarization.

bioRxiv · Apr 11, 2024 · PreprintImmunology

DeepMPS: Development and validation of a deep learning model for whole slide image base prognostic prediction of low grade Lung adenocarcinoma patients

A. Jagjampi, S. Khadirnaikar, P. S. Malik, D. Jain, N. MB, S. Shukla

This paper develops and validates DeepMPS, a deep learning model that predicts prognosis for low-grade lung adenocarcinoma patients using histopathological images and clinical data, showing strong survival prediction performance.

bioRxiv · Dec 27, 2022 · PreprintPathology